Scopus BioPharma
(OTC) SCPS
Scopus BioPharma Financials at a Glance
Market Cap
$16,800
Revenue (TTM)
$0.00
Net Income (TTM)
$8.70M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-5.73 (Low)
Dividend
$0.00
Beta (Volatility)
-5.73 (Low)
Price
$0.00
Volume
2,350
Open
$0.00
Price
$0.00
Volume
2,350
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
-5.73 (Low)
Price
$0.00
Volume
2,350
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
SCPS News
SCPS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Scopus BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Morris C. Laster, MD
Website
www.scopusbiopharma.comHeadquarters
New York City, NY 10170, US
SCPS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
2%
Return on Assets
-30%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.80K
Shares Outstanding
42.08M
Volume
2.35K
Short Interest
0.00%
Avg. Volume
1.18K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$11.71M
EBITDA
$11.71M
Operating Cash Flow
$8.13M
Capital Expenditure
$1.55K
Free Cash Flow
$8.13M
Cash & ST Invst.
$124.58K
Total Debt
$0.00
Scopus BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$16.80K
N/A
Market Cap/Employee
$1.29K
N/A
Employees
13
N/A
Net Income
$2.62M
+21.2%
EBITDA
$2.93M
+11.8%
Quarterly Fundamentals
Net Cash
$362.10K
-68.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-29.60%
N/A
Return on Invested Capital
1.66%
N/A
Free Cash Flow
$1.01M
+64.9%
Operating Cash Flow
$1.01M
+64.9%